Remarkably, 94% of participants in the supporting study who received Hemgenix were able to discontinue use of intravenous FIX infusions. This is an important consideration since FIX infusion therapy can cost of approximately $500,000–$750,000 per year.
Learn more about specialty pharmacy for health plan success! Fairview’s Tim Affeldt, Vice President of Specialty & Infusion, will present specialty pharmacy’s history, current state, and future challenges in a rapidly changing industry.
Currently, a significant proportion of the pharmaceutical development pipeline is represented by drugs used to treat rare diseases and, increasingly, gene therapies. For example, 44 drugs in ClearScript’s Brand Pipeline Forecast are used to treat rare diseases and are up for approval in the upcoming six months.
Learn everything you ever wanted to know about Pharmacy Benefit Management in Minnesota with this free course. ClearScript’s Kyle D. Johnson, Vice President of Sales, covers everything from what is a PBM and what they do, to current market status and all you need to know for better managing your pharmacy benefit plan.
ClearScript has been working with school districts for 20 years and we have a deep understanding of the complexity and high standards of school district benefit plans and union benefit offerings.
With years of experience in pharmacy benefit management for tribal nations, ClearScript respects the sovereignty of indigenous peoples and understands the Native American healthcare delivery system and the complexity of tribal programs.
We use comprehensive data analytics and a deep understanding of the pharmacy landscape to identify opportunities for improving financial performance and member health outcomes.